PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.\', \'School of Telecommunications Engineering, Universidad Politécnica de Madrid, Madrid, Spain.\', \'Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.\', \'Neumology Service, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.\', \'Neumology Service, Hospital de El Escorial, El Escorial, Spain.\', \'Family Medicine, Centro de Salud Doctor Pedro Laín Entralgo, Alcorcón, Spain.\', \'Internal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, Spain.\', \'Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, UT, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.665329
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34122423
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
?:type

Metadata

Anon_0  
expand all